Mark Anastasas

Group Lead Chemistry-QC at PYC Therapeutics

Speaker

Mark Anastasas has been a scientist with PYC Therapeutics for over 18 years. He has been involved in numerous peptide drug discovery projects and novel assay development. His external collaborations with Top 10 Pharma companies have involved research of cell penetrating peptides, anti-microbial peptides and peptide epitope mimetics.

Currently he is Group Lead of Chemistry-Quality Control and has been involved in assessing quality of in-house and external vendor materials with a focus on analytical method development. He also plays an active role in pre-formulation, clinical in-use compatibility, and biological matrix stability studies.

His interests include mass spectrometry, structure elucidation, bioanalysis of complex modalities and bridging the interface between chemistry and biology within the organisation.